Chengdu Kanghong Pharmaceutical Group Co., Ltd. (002773) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Why is Chengdu Kanghong Pharmaceutical Group Co., Ltd. ?

Positive results in Mar 25

OPERATING CASH FLOW(Y) Highest at CNY 1,486.73 MM
DEBT-EQUITY RATIO (HY) Lowest at -67.07 %
DEBTORS TURNOVER RATIO(HY) Highest at 22.58%

With ROE of 13.70%, it has a attractive valuation with a 2.85 Price to Book Value

Over the past year, while the stock has generated a return of 59.60%, its profits have risen by 1.2% ; the PEG ratio of the company is 17.3
At the current price, the company has a high dividend yield of 2.2

Market Beating Performance

The stock has generated a return of 59.60% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Chengdu Kanghong Pharmaceutical Group Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Chengdu Kanghong Pharmaceutical Group Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

52.04%

0.88

44.63%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.05%

EBIT Growth (5y)

13.67%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.67

Sales to Capital Employed (avg)

0.50

Tax Ratio

12.21%

Dividend Payout Ratio

46.33%

Pledged Shares

Institutional Holding

ROCE (avg)

24.39%

ROE (avg)

9.96%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.85

EV to EBIT

15.02

EV to EBITDA

12.69

EV to Capital Employed

6.74

EV to Sales

4.24

PEG Ratio

17.27

Dividend Yield

2.18%

ROCE (Latest)

44.83%

ROE (Latest)

13.70%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 1,486.73 MM

DEBT-EQUITY RATIO (HY)

Lowest at -67.07 %

DEBTORS TURNOVER RATIO(HY)

Highest at 22.58%

RAW MATERIAL COST(Y)

Fallen by -3.52% (YoY

CASH AND EQV(HY)

Highest at CNY 11,765.9 MM

NET SALES(Q)

Highest at CNY 1,185.42 MM

PRE-TAX PROFIT(Q)

Highest at CNY 463.9 MM

NET PROFIT(Q)

Highest at CNY 400.84 MM

EPS(Q)

Highest at CNY 0.43

-1What is not working for the Company

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.46%

Here's what is working for Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Operating Cash Flow

Highest at CNY 1,486.73 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Debt-Equity Ratio

Lowest at -67.07 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio

Highest at 22.58% and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Sales

Highest at CNY 1,185.42 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit

Highest at CNY 463.9 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 400.84 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.43

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv

Highest at CNY 11,765.9 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by -3.52% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Inventory Turnover Ratio

Lowest at 1.46%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio